Clinuvel Pharmaceuticals Ltd (CLVLY)
10.00
+0.04
(+0.45%)
USD |
OTCM |
Sep 23, 16:00
Clinuvel Pharmaceuticals Price to Book Value: 3.690 for Sept. 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 23, 2024 | 3.690 |
| September 20, 2024 | 3.674 |
| September 19, 2024 | 3.674 |
| September 18, 2024 | 3.611 |
| September 17, 2024 | 3.735 |
| September 16, 2024 | 3.690 |
| September 13, 2024 | 3.690 |
| September 12, 2024 | 3.654 |
| September 11, 2024 | 3.635 |
| September 10, 2024 | 3.561 |
| September 09, 2024 | 3.598 |
| September 06, 2024 | 3.478 |
| September 05, 2024 | 3.478 |
| September 04, 2024 | 3.702 |
| September 03, 2024 | 3.702 |
| August 30, 2024 | 3.801 |
| August 29, 2024 | 3.812 |
| August 28, 2024 | 3.482 |
| August 27, 2024 | 3.41 |
| August 26, 2024 | 3.414 |
| August 23, 2024 | 3.414 |
| August 22, 2024 | 3.299 |
| August 21, 2024 | 3.344 |
| August 20, 2024 | 3.380 |
| August 19, 2024 | 3.274 |
| Date | Value |
|---|---|
| August 16, 2024 | 3.451 |
| August 15, 2024 | 3.395 |
| August 14, 2024 | 3.469 |
| August 13, 2024 | 3.421 |
| August 12, 2024 | 3.454 |
| August 09, 2024 | 3.380 |
| August 08, 2024 | 3.356 |
| August 07, 2024 | 3.322 |
| August 06, 2024 | 3.403 |
| August 05, 2024 | 3.107 |
| August 02, 2024 | 3.488 |
| August 01, 2024 | 3.580 |
| July 31, 2024 | 3.650 |
| July 30, 2024 | 3.698 |
| July 29, 2024 | 3.690 |
| July 26, 2024 | 3.690 |
| July 25, 2024 | 3.598 |
| July 24, 2024 | 3.598 |
| July 23, 2024 | 3.786 |
| July 22, 2024 | 3.786 |
| July 19, 2024 | 3.761 |
| July 18, 2024 | 3.783 |
| July 17, 2024 | 3.761 |
| July 16, 2024 | 3.820 |
| July 15, 2024 | 3.820 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.107
Minimum
Aug 05 2024
32.77
Maximum
Oct 09 2019
11.44
Average
9.372
Median
Price to Book Value Benchmarks
| Alterity Therapeutics Ltd | -- |
| Kazia Therapeutics Ltd | 2.683 |
| Immutep Ltd | -- |
| Opthea Ltd | -- |
| Mesoblast Ltd | -- |
Price to Book Value Related Metrics
| PE Ratio | 21.81 |
| PS Ratio | 8.822 |
| PEG Ratio | 0.3731 |
| Price | 10.00 |
| Earnings Yield | 4.58% |
| Market Cap | 500.78M |
| PEGY Ratio | 0.3709 |
| Operating PE Ratio | 16.19 |
| Normalized PE Ratio | 21.81 |